Lorus says FDA allows piecemeal data on fast-track cancer drug Virulizin

TORONTO (CP) - Lorus Therapeutics Inc. announced Monday that the U.S. Food and Drug Administration is speeding the approval process of its previously fast-tracked Virulizin drug for pancreatic cancer....More